House Bill, 89th Legislature, Regular Session (2025)
HB 3317
Relating to the relationship between pharmacists or pharmacies and health benefit plan issuers or pharmacy benefit managers.
How far it got in 2025
Left House committee; never got a floor vote
Last official action May 12, 2025.
Who testified
Who signed up to testify at each committee hearing, and where they stood, from the committee's official witness list.
House Insurance, April 17, 2025
Official witness list16 for, 0 against, 2 on4 spoke at the hearing; the rest registered a position or sent written testimony. “On” means neither for nor against, often an agency answering questions.
Organizations represented (16)
- American Pharmaciesregistered lobby clientfor
- AstraZenecafor
- H-E-B, LPregistered lobby clientfor
- National Association of Chain Drug Stores (NACDS)for
- Teaching Hospitals of Texasregistered lobby clientfor
- Texas Association of Community Health Centers (TACHC)for
- Texas Association of Health Plansregistered lobby clienton
- Texas coalition for patientsregistered lobby clientfor
- Texas Department of Insuranceon
- Texas Federation of Drug Storesregistered lobby clientfor
Show 6 more
- Texas Health Resourcesregistered lobby clientfor
- Texas Healthcare and Bioscience Instituteregistered lobby clientfor
- Texas hospital associationregistered lobby clientfor
- Texas Medical Associationregistered lobby clientfor
- Texas Oncologyfor
- Texas Pharmacy Associationregistered lobby clientfor
2 people representing themselves
For (2): Sams, Shawn; Nicholas, Casey
Names appear as printed on the official list. “Registered lobby client” means the organization's name matches a client in 2025 lobby registrations filed with the Texas Ethics Commission; organizations whose names are spelled differently there aren't marked.
We keep a summary of each 2025 bill. Its full history, text, amendments, and votes are on Texas Legislature Online.